Pharmabiotics 2023 Conference

Events

March 21, 2023 - March 22, 2023
Lyon, France

Biomica VP R&D, Dr. Shiri Meshner, to present at the Pharmabiotics 2023 conference. Company presenation entitled: “Biomica’s BMC128 – a Rationally Designed LBP Consortium’s Journey to the Clinic.”

Back to all News

Media

Jun 10, 2024

ASCO 2024: The latest advances in oncology clinical trials

Media

May 26, 2024

Promising clinical trial for cancer treatment using gut microbes

News

May 23, 2024

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting REHOVOT, Israel, May 23, 2024. Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: […]

Pharmabiotics 2023 Conference

Highlighted News About Biomica

ASCO 2024: The latest advances in oncology clinical trials

Promising clinical trial for cancer treatment using gut microbes

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Contact Us